Published in J Virol on May 01, 1997
Directed egress of animal viruses promotes cell-to-cell spread. J Virol (2002) 2.72
Mutational analysis of the role of glycoprotein I in varicella-zoster virus replication and its effects on glycoprotein E conformation and trafficking. J Virol (1997) 2.34
Role of envelope protein gE endocytosis in the pseudorabies virus life cycle. J Virol (1998) 2.32
Herpes simplex virus gE/gI sorts nascent virions to epithelial cell junctions, promoting virus spread. J Virol (2001) 2.18
Role of the cytoplasmic tail of pseudorabies virus glycoprotein E in virion formation. J Virol (2000) 2.17
The herpes simplex virus gE-gI complex facilitates cell-to-cell spread and binds to components of cell junctions. J Virol (1998) 2.14
Mutation of the YXXL endocytosis motif in the cytoplasmic tail of pseudorabies virus gE. J Virol (1999) 2.13
Human cytomegalovirus pp28 (UL99) localizes to a cytoplasmic compartment which overlaps the endoplasmic reticulum-golgi-intermediate compartment. J Virol (2000) 1.93
Cytoplasmic domain of herpes simplex virus gE causes accumulation in the trans-Golgi network, a site of virus envelopment and sorting of virions to cell junctions. J Virol (2001) 1.91
Intracellular traffic of herpes simplex virus glycoprotein gE: characterization of the sorting signals required for its trans-Golgi network localization. J Virol (1999) 1.87
Characterization of pseudorabies virus mutants expressing carboxy-terminal truncations of gE: evidence for envelope incorporation, virulence, and neurotropism domains. J Virol (1997) 1.79
Herpes simplex virus type 1 capsids transit by the trans-Golgi network, where viral glycoproteins accumulate independently of capsid egress. J Virol (2005) 1.69
The extracellular domain of herpes simplex virus gE is sufficient for accumulation at cell junctions but not for cell-to-cell spread. J Virol (2000) 1.65
Complex formation facilitates endocytosis of the varicella-zoster virus gE:gI Fc receptor. J Virol (1998) 1.62
Essential role played by the C-terminal domain of glycoprotein I in envelopment of varicella-zoster virus in the trans-Golgi network: interactions of glycoproteins with tegument. J Virol (2001) 1.55
Intracellular trafficking and localization of the pseudorabies virus Us9 type II envelope protein to host and viral membranes. J Virol (1999) 1.47
Directional transneuronal infection by pseudorabies virus is dependent on an acidic internalization motif in the Us9 cytoplasmic tail. J Virol (2000) 1.42
Herpes simplex virus gE/gI must accumulate in the trans-Golgi network at early times and then redistribute to cell junctions to promote cell-cell spread. J Virol (2006) 1.39
Mutation of the dominant endocytosis motif in human immunodeficiency virus type 1 gp41 can complement matrix mutations without increasing Env incorporation. J Virol (2002) 1.37
Varicella-zoster virus ORF47 protein serine kinase: characterization of a cloned, biologically active phosphotransferase and two viral substrates, ORF62 and ORF63. J Virol (2001) 1.37
Glycoprotein I of varicella-zoster virus is required for viral replication in skin and T cells. J Virol (2002) 1.29
Promoter sequences of varicella-zoster virus glycoprotein I targeted by cellular transactivating factors Sp1 and USF determine virulence in skin and T cells in SCIDhu mice in vivo. J Virol (2003) 1.25
Retracted Basic residues of the helix six domain of influenza virus M1 involved in nuclear translocation of M1 can be replaced by PTAP and YPDL late assembly domain motifs. J Virol (2003) 1.23
Herpes simplex virus gD and virions accumulate in endosomes by mannose 6-phosphate-dependent and -independent mechanisms. J Virol (1998) 1.18
Functions of the C-terminal domain of varicella-zoster virus glycoprotein E in viral replication in vitro and skin and T-cell tropism in vivo. J Virol (2004) 1.17
An acidic cluster in the cytosolic domain of human cytomegalovirus glycoprotein B is a signal for endocytosis from the plasma membrane. J Virol (1999) 1.15
Varicella-zoster virus Fc receptor component gI is phosphorylated on its endodomain by a cyclin-dependent kinase. J Virol (1999) 1.13
Endocytosis of the Nipah virus glycoproteins. J Virol (2005) 1.12
Effects of mutations in the cytoplasmic domain of herpes simplex virus type 1 glycoprotein B on intracellular transport and infectivity. J Virol (2004) 1.10
Essential functions of the unique N-terminal region of the varicella-zoster virus glycoprotein E ectodomain in viral replication and in the pathogenesis of skin infection. J Virol (2006) 1.10
Incorporation of three endocytosed varicella-zoster virus glycoproteins, gE, gH, and gB, into the virion envelope. J Virol (2005) 1.04
Bovine herpesvirus 5 glycoprotein E is important for neuroinvasiveness and neurovirulence in the olfactory pathway of the rabbit. J Virol (2000) 1.04
A functional YNKI motif in the short cytoplasmic tail of varicella-zoster virus glycoprotein gH mediates clathrin-dependent and antibody-independent endocytosis. J Virol (2003) 1.02
Egress of light particles among filopodia on the surface of Varicella-Zoster virus-infected cells. J Virol (2008) 1.01
Glycoprotein E of varicella-zoster virus enhances cell-cell contact in polarized epithelial cells. J Virol (2000) 1.00
A tyrosine motif in the cytoplasmic domain of mason-pfizer monkey virus is essential for the incorporation of glycoprotein into virions. J Virol (2003) 0.99
Regulation of varicella-zoster virus-induced cell-to-cell fusion by the endocytosis-competent glycoproteins gH and gE. J Virol (2004) 0.98
Role of the varicella-zoster virus gB cytoplasmic domain in gB transport and viral egress. J Virol (2002) 0.97
Contribution of endocytic motifs in the cytoplasmic tail of herpes simplex virus type 1 glycoprotein B to virus replication and cell-cell fusion. J Virol (2007) 0.96
The Rous sarcoma virus Env glycoprotein contains a highly conserved motif homologous to tyrosine-based endocytosis signals and displays an unusual internalization phenotype. Mol Cell Biol (2000) 0.96
Human cytomegalovirus glycoprotein B contains autonomous determinants for vectorial targeting to apical membranes of polarized epithelial cells. J Virol (1998) 0.95
Identification of two intracellular mechanisms leading to reduced expression of oncoretrovirus envelope glycoproteins at the cell surface. J Virol (2000) 0.95
Development of recombinant varicella-zoster viruses expressing luciferase fusion proteins for live in vivo imaging in human skin and dorsal root ganglia xenografts. J Virol Methods (2008) 0.95
Functions of the unique N-terminal region of glycoprotein E in the pathogenesis of varicella-zoster virus infection. Proc Natl Acad Sci U S A (2009) 0.94
Cytoplasmic domain signal sequences that mediate transport of varicella-zoster virus gB from the endoplasmic reticulum to the Golgi. J Virol (2000) 0.92
Deletion of gpUL132, a structural component of human cytomegalovirus, results in impaired virus replication in fibroblasts. J Virol (2005) 0.91
Investigating the mechanism of acoustically activated uptake of drugs from Pluronic micelles. BMC Cancer (2002) 0.89
A glycine-rich bovine herpesvirus 5 (BHV-5) gE-specific epitope within the ectodomain is important for BHV-5 neurovirulence. J Virol (2004) 0.87
Kinetics of antibody-induced modulation of respiratory syncytial virus antigens in a human epithelial cell line. Virol J (2007) 0.87
A bovine herpesvirus type 1 mutant virus specifying a carboxyl-terminal truncation of glycoprotein E is defective in anterograde neuronal transport in rabbits and calves. J Virol (2008) 0.86
The herpes virus Fc receptor gE-gI mediates antibody bipolar bridging to clear viral antigens from the cell surface. PLoS Pathog (2014) 0.85
Insulin-degrading enzyme binds to the nonglycosylated precursor of varicella-zoster virus gE protein found in the endoplasmic reticulum. J Virol (2009) 0.81
Exocytosis of Varicella-Zoster Virus Virions Involves a Convergence of Endosomal and Autophagy Pathways. J Virol (2016) 0.79
Optimal replication of human cytomegalovirus correlates with endocytosis of glycoprotein gpUL132. J Virol (2010) 0.77
Preventing Cleavage of the Respiratory Syncytial Virus Attachment Protein in Vero Cells Rescues the Infectivity of Progeny Virus for Primary Human Airway Cultures. J Virol (2015) 0.76
Varicella-Zoster Virus Glycoproteins: Entry, Replication, and Pathogenesis. Curr Clin Microbiol Rep (2016) 0.75
The complete DNA sequence of varicella-zoster virus. J Gen Virol (1986) 16.00
Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. Annu Rev Cell Biol (1985) 11.53
Product review. New mammalian expression vectors. Nature (1990) 7.97
Interaction of tyrosine-based sorting signals with clathrin-associated proteins. Science (1995) 7.77
Signal-dependent membrane protein trafficking in the endocytic pathway. Annu Rev Cell Biol (1993) 7.16
A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science (1990) 4.90
A novel class of clathrin-coated vesicles budding from endosomes. J Cell Biol (1996) 4.05
The low density lipoprotein receptor. Identification of amino acids in cytoplasmic domain required for rapid endocytosis. J Biol Chem (1987) 3.84
Transferrin receptor internalization sequence YXRF implicates a tight turn as the structural recognition motif for endocytosis. Cell (1990) 3.75
Coated pits act as molecular filters. Proc Natl Acad Sci U S A (1980) 3.56
The J.D. mutation in familial hypercholesterolemia: amino acid substitution in cytoplasmic domain impedes internalization of LDL receptors. Cell (1986) 3.44
A single amino acid change in the cytoplasmic domain allows the influenza virus hemagglutinin to be endocytosed through coated pits. Cell (1988) 3.26
Internalization-defective LDL receptors produced by genes with nonsense and frameshift mutations that truncate the cytoplasmic domain. Cell (1985) 3.13
Quantification of low density lipoprotein and transferrin endocytic sorting HEp2 cells using confocal microscopy. J Cell Sci (1994) 2.88
Casein kinases--multipotential protein kinases. Curr Top Cell Regul (1982) 2.85
Molecular phylogeny and evolutionary timescale for the family of mammalian herpesviruses. J Mol Biol (1995) 2.84
Receptor-mediated endocytosis. Biochem J (1985) 2.73
Endocytosis of endogenously synthesized HIV-1 envelope protein. Mechanism and role in processing for association with class II MHC. J Immunol (1995) 2.62
Deletion of the cytoplasmic domain of the polymeric immunoglobulin receptor prevents basolateral localization and endocytosis. Cell (1986) 2.56
Glycoproteins E and I facilitate neuron-to-neuron spread of herpes simplex virus. J Virol (1995) 2.52
A mutant insulin receptor with defective tyrosine kinase displays no biologic activity and does not undergo endocytosis. J Biol Chem (1987) 2.48
Targeting of membrane proteins to endosomes and lysosomes. Trends Cell Biol (1994) 2.38
Heterologous transmembrane and cytoplasmic domains direct functional chimeric influenza virus hemagglutinins into the endocytic pathway. J Cell Biol (1986) 2.37
A single amino acid change in the cytoplasmic domain of the simian immunodeficiency virus transmembrane molecule increases envelope glycoprotein expression on infected cells. J Virol (1995) 2.35
Endocytosis and signals for internalization. Curr Opin Cell Biol (1991) 2.22
Evidence for nonvectorial, retrograde transferrin trafficking in the early endosomes of HEp2 cells. J Cell Biol (1995) 2.19
Structural analysis of the varicella-zoster virus gp98-gp62 complex: posttranslational addition of N-linked and O-linked oligosaccharide moieties. J Virol (1985) 2.09
An internalization signal in the simian immunodeficiency virus transmembrane protein cytoplasmic domain modulates expression of envelope glycoproteins on the cell surface. J Cell Biol (1996) 2.06
Endocytosis of the transferrin receptor requires the cytoplasmic domain but not its phosphorylation site. Cell (1987) 1.98
Glycoproteins encoded by varicella-zoster virus: biosynthesis, phosphorylation, and intracellular trafficking. Annu Rev Microbiol (1990) 1.92
Egress of varicella-zoster virus from the melanoma cell: a tropism for the melanocyte. J Virol (1995) 1.89
A casein kinase II phosphorylation site in the cytoplasmic domain of the cation-dependent mannose 6-phosphate receptor determines the high affinity interaction of the AP-1 Golgi assembly proteins with membranes. J Biol Chem (1996) 1.81
Receptor properties of two varicella-zoster virus glycoproteins, gpI and gpIV, homologous to herpes simplex virus gE and gI. J Virol (1992) 1.81
Varicella-zoster virus Fc receptor gE glycoprotein: serine/threonine and tyrosine phosphorylation of monomeric and dimeric forms. J Virol (1997) 1.50
The mechanism of receptor-mediated endocytosis: more questions than answers. Bioessays (1992) 1.50
Site-directed mutagenesis of herpesvirus glycoprotein phosphorylation sites by recombination polymerase chain reaction. PCR Methods Appl (1992) 1.49
Identification of the phosphorylation sequence in the cytoplasmic tail of the varicella-zoster virus Fc receptor glycoprotein gpI. J Virol (1993) 1.40
Transplanted LDL and mannose-6-phosphate receptor internalization signals promote high-efficiency endocytosis of the transferrin receptor. EMBO J (1991) 1.34
Cell surface expression of the varicella-zoster virus glycoproteins and Fc receptor. Virology (1990) 1.29
Neurovirulence of pseudorabies virus. Crit Rev Neurobiol (1995) 1.26
Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects. Cancer Res (1990) 1.24
Tyrosine phosphorylation provides an obligatory early signal for Fc gamma RII-mediated endocytosis in the monocytic cell line THP-1. J Immunol (1994) 1.10
Phosphorylation of serine 833 in cytoplasmic domain of low density lipoprotein receptor by a high molecular weight enzyme resembling casein kinase II. J Biol Chem (1987) 1.06
Visualization of the thyrotropin-releasing hormone receptor and its ligand during endocytosis and recycling. Proc Natl Acad Sci U S A (1995) 1.02
The eighth Datta Lecture. Molecular mechanisms in synaptic vesicle recycling. FEBS Lett (1995) 0.99
Epitope mapping and tagging by recombination PCR mutagenesis. Biotechniques (1997) 0.95
Receptor cell biology: receptor-mediated endocytosis. Pediatr Res (1995) 0.84
Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J Virol (1998) 2.48
Partner's influence on patient preference for treatment in early prostate cancer. BJU Int (2003) 2.33
Role of cytoplasmic vacuoles in varicella-zoster virus glycoprotein trafficking and virion envelopment. J Virol (1988) 2.22
Varicella-zoster virus: isolation and propagation in human melanoma cells at 36 and 32 degrees C. Infect Immun (1978) 2.15
Structural analysis of the varicella-zoster virus gp98-gp62 complex: posttranslational addition of N-linked and O-linked oligosaccharide moieties. J Virol (1985) 2.09
Primary Epstein-Barr-virus infections in acute neurologic diseases. N Engl J Med (1975) 2.02
Varicella-zoster virus gE escape mutant VZV-MSP exhibits an accelerated cell-to-cell spread phenotype in both infected cell cultures and SCID-hu mice. Virology (2000) 1.99
Phosphorylation of varicella-zoster virus open reading frame (ORF) 62 regulatory product by viral ORF 47-associated protein kinase. J Virol (1994) 1.99
Monoclonal antibodies against three major glycoproteins of varicella-zoster virus. Infect Immun (1983) 1.95
Egress of varicella-zoster virus from the melanoma cell: a tropism for the melanocyte. J Virol (1995) 1.89
Receptor properties of two varicella-zoster virus glycoproteins, gpI and gpIV, homologous to herpes simplex virus gE and gI. J Virol (1992) 1.81
The synthesis of glycoproteins in human melanoma cells infected with varicella-zoster virus. Virology (1980) 1.72
Cell surface expression and fusion by the varicella-zoster virus gH:gL glycoprotein complex: analysis by laser scanning confocal microscopy. Virology (1995) 1.72
Variation on a theme by Fenner: the pathogenesis of chickenpox. Pediatrics (1981) 1.69
Cell-free varicella-zoster virus in cultured human melanoma cells. J Gen Virol (1979) 1.64
Complex formation facilitates endocytosis of the varicella-zoster virus gE:gI Fc receptor. J Virol (1998) 1.62
New common nomenclature for glycoprotein genes of varicella-zoster virus and their glycosylated products. J Virol (1986) 1.59
Varicella-zoster virus glycoprotein gpI/gpIV receptor: expression, complex formation, and antigenicity within the vaccinia virus-T7 RNA polymerase transfection system. J Virol (1993) 1.58
Consensus: varicella-zoster infections in pregnancy and the perinatal period. Pediatr Infect Dis J (1990) 1.53
Mutational analysis of the repeated open reading frames, ORFs 63 and 70 and ORFs 64 and 69, of varicella-zoster virus. J Virol (2001) 1.53
Identification and mapping of single nucleotide polymorphisms in the varicella-zoster virus genome. Virology (2001) 1.50
Varicella-zoster virus Fc receptor gE glycoprotein: serine/threonine and tyrosine phosphorylation of monomeric and dimeric forms. J Virol (1997) 1.50
Site-directed mutagenesis of herpesvirus glycoprotein phosphorylation sites by recombination polymerase chain reaction. PCR Methods Appl (1992) 1.49
Varicella-zoster virus-specific gp140: a highly immunogenic and disulfide-linked structural glycoprotein. Virology (1984) 1.49
Multiple regulatory effects of varicella-zoster virus (VZV) gL on trafficking patterns and fusogenic properties of VZV gH. J Virol (1996) 1.49
Serine protein kinase associated with varicella-zoster virus ORF 47. Virology (1992) 1.48
Neutralization epitope of the varicella-zoster virus gH:gL glycoprotein complex. Virology (1994) 1.46
Pyomyositis in an adolescent female athlete. J Pediatr Surg (1995) 1.43
Complement-enhanced neutralizing antibody response to varicella-zoster virus. J Infect Dis (1979) 1.40
Identification of the phosphorylation sequence in the cytoplasmic tail of the varicella-zoster virus Fc receptor glycoprotein gpI. J Virol (1993) 1.40
Genomic cartography of varicella-zoster virus: a complete genome-based analysis of strain variability with implications for attenuation and phenotypic differences. Virology (2006) 1.39
Common expression of varicella-zoster viral glycoprotein antigens in vitro and in chickenpox and zoster vesicles. J Infect Dis (1983) 1.39
Varicella-zoster virus ORF47 protein serine kinase: characterization of a cloned, biologically active phosphotransferase and two viral substrates, ORF62 and ORF63. J Virol (2001) 1.37
Entry and egress of varicella virus blocked by same anti-gH monoclonal antibody. Virology (1993) 1.36
Antigenic variation of varicella zoster virus Fc receptor gE: loss of a major B cell epitope in the ectodomain. Virology (1998) 1.35
Varicella-zoster Virus gB and gE coexpression, but not gB or gE alone, leads to abundant fusion and syncytium formation equivalent to those from gH and gL coexpression. J Virol (2001) 1.29
Cell surface expression of the varicella-zoster virus glycoproteins and Fc receptor. Virology (1990) 1.29
Interactions among structural proteins of varicella zoster virus. Arch Virol Suppl (2001) 1.27
Neutralization epitope of varicella zoster virus on native viral glycoprotein gp118 (VZV glycoprotein gpIII). Virology (1986) 1.23
Chaperone functions common to nonhomologous Epstein-Barr virus gL and Varicella-Zoster virus gL proteins. J Virol (1997) 1.18
Varicella zoster virus glycoprotein gpI is selectively phosphorylated by a virus-induced protein kinase. Proc Natl Acad Sci U S A (1986) 1.18
Bell's palsy and infectious mononucleosis. Lancet (1973) 1.17
Immunity to varicella-zoster viral glycoproteins, gp I (gp 90/58) and gp III (gp 118), and to a nonglycosylated protein, p 170. J Immunol (1986) 1.15
Varicella-zoster virus Fc receptor component gI is phosphorylated on its endodomain by a cyclin-dependent kinase. J Virol (1999) 1.13
Molecular dissection of the humoral immune response to individual varicella-zoster viral proteins during chickenpox, quiescence, reinfection, and reactivation. J Infect Dis (1984) 1.13
Unusual phosphorylation sequence in the gpIV (gI) component of the varicella-zoster virus gpI-gpIV glycoprotein complex (VZV gE-gI complex). J Virol (1994) 1.13
Assembly and processing of the disulfide-linked varicella-zoster virus glycoprotein gpII(140). J Virol (1987) 1.07
Human leukocytes kill varicella-zoster virus-infected fibroblasts in the presence of murine monoclonal antibodies to virus-specific glycoproteins. J Virol (1985) 1.03
Epstein-Barr virus and Guillain-Barré syndrome. Lancet (1972) 1.03
Herpesvirus antibody levels in the etiologic diagnosis of the acute retinal necrosis syndrome. Am J Ophthalmol (1992) 1.02
Cryopreservation of varicella-zoster virions without loss of structural integrity or infectivity. Intervirology (1981) 1.02
Immunoprecipitable polypeptides specified by varicella-zoster virus. Virology (1982) 1.01
Varicella-zoster virus p32/p36 complex is present in both the viral capsid and the nuclear matrix of the infected cell. J Virol (1986) 1.00
Immunogenic glycoproteins of laboratory and vaccine strains of Varicella-Zoster virus. Infect Immun (1981) 0.99
Cellular and humoral immunity to varicella zoster virus glycoproteins in immune and susceptible human subjects. J Infect Dis (1989) 0.98
Purification and molecular anatomy of the varicella-zoster virion. Biken J (1983) 0.96
Varicella-zoster viral glycoprotein envelopment: ultrastructural cytochemical localization. J Histochem Cytochem (1986) 0.95
Epitope mapping and tagging by recombination PCR mutagenesis. Biotechniques (1997) 0.95
Zoster in children with cancer: radioimmune precipitation profiles of sera before and after illness. J Infect Dis (1983) 0.95
Varicella-zoster virus glycoprotein gE: endocytosis and trafficking of the Fc receptor. J Infect Dis (1998) 0.93
Primary Epstein-Barr virus infection in a renal transplant recipient. South Med J (1977) 0.92
Mechanism of selective nonspecific cell-mediated cytotoxicity of virus-infected cells. Nature (1976) 0.92
Glycoprotein gp118 of varicella-zoster virus: purification by serial affinity chromatography. J Virol (1984) 0.91
Immunization of inbred guinea pigs with varicella-zoster virus grown in a syngeneic transformed embryo cell line. J Clin Microbiol (1981) 0.90
DNA mapping of paired varicella-zoster virus isolates from patients with shingles. Lancet (1983) 0.89
Genomic analysis of varicella-zoster virus: primers for individual open reading frames. J Clin Virol (2003) 0.88
Transformation of primary chick embryo fibroblasts by Marek's disease virus. Virology (1997) 0.88
Cerebroside antibody titers in antisera capable of myelination inhibition and demyelination. Brain Res (1978) 0.86
Pyomyositis presenting as acute abdominal pain. Pediatr Infect Dis (1984) 0.85
Multimeric humanized varicella-zoster virus antibody fragments to gH neutralize virus while monomeric fragments do not. J Gen Virol (2001) 0.85
Magnetic resonance imaging of the brain in childhood herpesvirus infections. Pediatr Infect Dis J (1987) 0.85
Cellular immunodeficiency associated with nucleoside phosphorylase deficiency. Immunologic and biochemical studies. Clin Immunol Immunopathol (1977) 0.84
Epstein-Barr virus and transverse myelitis. Lancet (1973) 0.82
Prenatal diagnosis of congenital cytomegalovirus infection by virus isolation from amniotic fluid. Am J Obstet Gynecol (1990) 0.82
Varicella pneumonitis: immunodiagnosis with a monoclonal antibody. J Pediatr (1984) 0.81
Insulin-degrading enzyme binds to the nonglycosylated precursor of varicella-zoster virus gE protein found in the endoplasmic reticulum. J Virol (2009) 0.81
Herpesviral Fc receptors and their relationship to the human Fc receptors. Immunol Res (1992) 0.80
Subacute sclerosing panencephalitis, a measles complication, in an internationally adopted child. Emerg Infect Dis (2000) 0.80
Bad consequences of bicycle accidents. Pyomyositis. Pediatr Infect Dis J (1994) 0.79
Letter: Measles associated with Bell palsy. Am J Dis Child (1975) 0.79
Staphylococcal pyomyositis in South Texas. J Pediatr (1978) 0.79
Guillain-Barré syndrome following administration of live measles vaccine. Am J Med (1976) 0.78
IgM and IgG responses to varicella-zoster virus p32/p36 complex after chickenpox and zoster, congenital and subclinical infections, and vaccination. J Infect Dis (1989) 0.78
Fatal pertussis in an Iowa infant. Iowa Med (1991) 0.78
Sabin inactivated trivalent poliovirus vaccine: first clinical trial and seroimmunity survey. Pediatr Infect Dis J (1988) 0.78
Complete spectrum of the varicella congenital defects syndrome in 5-year-old child. Pediatr Infect Dis (1984) 0.78
Biotinylated and radioactive DNA probes for detection of varicella-zoster virus genome in infected human cells. Mol Cell Probes (1988) 0.78
Magnetic resonance imaging for early diagnosis of necrotizing fasciitis. Pediatr Emerg Care (1993) 0.78
Varicella-zoster virus with a lost gE epitope: evidence for immunological pressure by the human antibody response. Arch Virol Suppl (2001) 0.77
Prenatal diagnosis of second-trimester congenital varicella syndrome by virus-specific immunoglobulin M. J Pediatr (1987) 0.77
The cell surface in amoeboid locomotion--studies on the role of cell-substrate adhesion. Cell Biol Int Rep (1982) 0.76
Epstein-Barr virus: the hematologic and oncologic consequences of virus-host interaction. Crit Rev Oncol Hematol (1989) 0.76
Ceftriaxone vs cefotaxime for treatment of Haemophilus influenzae meningitis. Pediatrics (1990) 0.75
Pyomyositis in children in the United States. Rev Infect Dis (1991) 0.75
Letter: Facial palsy and infectious mononucleosis. Arch Otolaryngol (1974) 0.75
Pathogenesis of central nervous system disease caused by varicella virus. Pediatr Infect Dis (1986) 0.75
Letter: Guillain-Barré syndrome. Am J Dis Child (1974) 0.75
Characterization of an enterovirus associated with acute infectious lymphocytosis. J Gen Virol (1976) 0.75